DK153486C - Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat - Google Patents

Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat

Info

Publication number
DK153486C
DK153486C DK278879A DK278879A DK153486C DK 153486 C DK153486 C DK 153486C DK 278879 A DK278879 A DK 278879A DK 278879 A DK278879 A DK 278879A DK 153486 C DK153486 C DK 153486C
Authority
DK
Denmark
Prior art keywords
preparation
formimidoyl
thienamycine
crystallinic
monohydrate
Prior art date
Application number
DK278879A
Other languages
English (en)
Other versions
DK153486B (da
DK278879A (da
Inventor
Thomas W Miller
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK278879A publication Critical patent/DK278879A/da
Publication of DK153486B publication Critical patent/DK153486B/da
Application granted granted Critical
Publication of DK153486C publication Critical patent/DK153486C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK278879A 1978-07-03 1979-07-02 Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat DK153486C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92137978A 1978-07-03 1978-07-03
US92137978 1978-07-03

Publications (3)

Publication Number Publication Date
DK278879A DK278879A (da) 1980-01-04
DK153486B DK153486B (da) 1988-07-18
DK153486C true DK153486C (da) 1988-11-28

Family

ID=25445341

Family Applications (1)

Application Number Title Priority Date Filing Date
DK278879A DK153486C (da) 1978-07-03 1979-07-02 Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat

Country Status (6)

Country Link
EP (1) EP0006639B1 (da)
JP (1) JPS559090A (da)
AT (1) ATE1676T1 (da)
DE (1) DE2963882D1 (da)
DK (1) DK153486C (da)
IE (1) IE48356B1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR70784B (da) * 1979-11-02 1983-03-23 Merck & Co Inc
US4374772A (en) * 1981-03-19 1983-02-22 Merck & Co., Inc. Process for the preparation of N-formimidoyl thienamycin and reagents therefor
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
JPS61207617A (ja) * 1985-03-05 1986-09-16 Toyobo Co Ltd ポリエステル繊維の製造方法
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
BR0214209A (pt) * 2001-11-16 2004-10-26 Ranbaxy Lab Ltd Processo para a preparação de imipenem cristalino e composto preparado pelo dito processo
CN100497338C (zh) * 2006-01-05 2009-06-10 上海医药工业研究院 4-甲基-7-氧-1-氮杂双环[3.2.0]庚-2-烯-2-羧酸类衍生物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE848545A (fr) * 1975-11-21 1977-05-20 Derives n-methylene substitues de thienamycine,
NZ182630A (en) * 1975-11-21 1979-07-11 Merck & Co Inc Substituted n-methylene dervatives of thienamycin and pharmaceutical compositions

Also Published As

Publication number Publication date
DK153486B (da) 1988-07-18
JPH0248557B2 (da) 1990-10-25
ATE1676T1 (de) 1982-11-15
DE2963882D1 (en) 1982-11-25
EP0006639A1 (en) 1980-01-09
JPS559090A (en) 1980-01-22
IE48356B1 (en) 1984-12-26
EP0006639B1 (en) 1982-10-20
DK278879A (da) 1980-01-04
IE791191L (en) 1980-01-03

Similar Documents

Publication Publication Date Title
CA1032763A (en) Method for the alteration of a lens
GB1553190A (en) Process for controlling the productivity of cultivated plants
DE2967090D1 (en) Process for the manufacture of field-effect transistors
DK148141C (da) Analogifremgangsmaade til fremstilling af phosphonylacetylproliner
PT69955B (pt) Process for preparing a combination of thienamycin-type anibiotics with dipeptidase inhibitors
DK0421081T3 (da) Fremgangsmåde til fremstilling af 23-(C1-C6-alkyloxim)-LL-F28249-forbindelser
DK153486C (da) Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
DK73179A (da) Fremgangsmaade til steroselektiv spaltning af dl-phenylglycinderivater
YU39499B (en) Process for the manufacture of optically active substituted azabicyclohexanes
DK63388A (da) Isocyanomethylforbindelse samt fremgangsmaade til fremstilling af et oxadiazolimidazobenzodiazepinderivat
DK148259C (da) Fremgangsmaade til fremstilling af lysergolderivater
NO924690L (no) Fremgangsmaate for fremstilling av mono-n-substituerte tetraazakrocykluser
JPS5688278A (en) Method of manufacturing light source
DK129779A (da) Fremgangsmaade til omdannelse af penicillinsulfoxidestere
DK178180A (da) Fremgangsmaade til frmstilling af 3-(hydroxyethyl) azetidiononer
DK11879A (da) Fremgangsmaade til fremstilling af krystallinsk maltose
DK412980A (da) Fremgangsmaade til fremstilling af penicillinforbindelser
DK77179A (da) Fremgangsmaade til fremstilling af androstadiener
DK157401C (da) Analogifremgangsmaade til fremstilling af substituerede n-methylenderivater af thienamycin
YU91079A (en) Process for the stabilization of 4-methyl-(2-chloroethyl)thiazole
DK209380A (da) Fremgangsmaade til fremstilling af krystalliserede cephalosporinsalte
AU521790B2 (en) Process for eradication of ticks
DE3588208D1 (de) Cephalosporinderivative
AU7354981A (en) Alpha-substituted ureidobenzylpenicillanic acid and process for producing the same
YU41072B (en) Process for the cultivation of basidionycetes